The human cadherin-10 gene: complete coding sequence, predominant expression in the brain, and mapping on chromosome 5p13–14  by Kools, Patrick et al.
The human cadherin-10 gene: complete coding sequence, predominant
expression in the brain, and mapping on chromosome 5p13^14
Patrick Kools, Koen Vanhalst, Eveline Van den Eynde, Frans van Roy*
Molecular Cell Biology Unit, Department of Molecular Biology, Flanders Interuniversity Institute for Biotechnology (VIB) - University of Ghent,
Ledeganckstraat 35, B-9000 Ghent, Belgium
Received 18 February 1999; received in revised form 6 May 1999
Abstract In a quest for novel cadherin gene family members in
the human dbEST database, an interesting EST clone was
identified and chosen for subsequent analysis. Using the
technique of 5P rapid amplification of cDNA ends, we isolated
the complete coding sequence and a large part of the UTRs of a
novel gene. The sequence appeared to correspond to the human
cadherin-10 gene, whose sequence was only partially known
before. The expression pattern of this cadherin was found to be
largely brain-specific, with additional expression in both adult
and fetal kidney, and with minor expression in prostate and fetal
lung. By FISH analysis the genomic location was determined at
human chromosome 5p13^14, which is nearby the reported
positions of the human cadherin-6, -12, and cadherin-14
(CDH18) genes. Cadherin-10 shows high relationship to the
human cadherin-6 gene.
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1. Introduction
Multicellular organisms depend for their structure and or-
ganization on their intercellular contacts. This was demon-
strated in developmental studies and in the study of cancer,
where loss of cell-cell adhesion contributes to the malignant
character of tumor cells. These ¢ndings stimulated the char-
acterization of a large number of cell-cell adhesion molecules,
among which the cadherins.
Classical cadherins are calcium-dependent intercellular gly-
coproteins containing ¢ve extracellular cadherin repeats of
about 110 amino acid residues with typically conserved se-
quences [1]. The extracellular cadherin domains bind Ca2,
which is necessary for correct protein folding and normal
functioning [2]. Additionally, most cadherins contain a trans-
membrane and a cytoplasmic domain. The cytoplasmic do-
mains are often linked via the catenins to the cytoskeleton
[3]. This structure is a general feature of most cadherins, not-
withstanding the presence of several intermolecular di¡erences
[4].
Despite the large number of cadherins already identi¢ed,
some of the cadherin-like sequences are still partial [5^9].
Their identi¢cation was based on the use of degenerate prim-
ers designed on well conserved sequences. In our study we
aimed at the isolation of still new family members by in silico
detection, i.e. screening of public domain databases contain-
ing data of expressed sequences (ESTs). This allowed us to
identify at least ten new cadherin-like genes.
We report here the characterization of one of those novel
family members, which turned out to be identical to the iden-
ti¢ed but only partially published human cadherin-10 cDNA
[7]. We present here the complete coding sequence of this
gene, a large part of the 5P untranslated region (UTR), and
presumably its complete 3P UTR. Additionally, the expression
pattern and chromosomal localization were determined. Fur-
thermore, phylogenetic analysis using the cadherin-10 protein
sequence demonstrated a close relationship to the previously
reported mouse T2-cadherin [10].
2. Materials and methods
2.1. In silico detection and analysis
The public domain databases dbEST, Genbank and EMBL were
screened with a simple ‘cadherin’ word search. All hits were analyzed
by BLAST searches [11] and sequence alignments (SeqMan 3.57; La-
sergene, DNASTAR, Madison, WI, USA).
Cadherin protein sequences used for phylogenetic analysis were
deduced by in silico translation of the cDNA sequences: Genbank
Acc. No. P12830 (human E-cadherin), P19022 (human N-cadherin),
I34427 (rat cadherin-10), AB000512 (chicken cadherin-10), D31784
(human cadherin-6), D82029 (mouse cadherin-6), P55280 (rat cadher-
in-6), D42149 (chicken cadherin-6B), U69137 (mouse cadherin-T2),
L34060 (human cadherin-8), and L34057 (human cadherin-12). A se-
quence editor was used to select the carboxy-terminal 265 amino acid
residues of each translated product. Multiple sequence alignment was
performed using CLUSTAL (MegAlign; DNASTAR) software.
2.2. DNA isolation, probe preparation and radioactive labeling
The cadherin-10 EST clone was obtained from the I.M.A.G.E.
consortium UK-HGMP Resource Centre (Hinxton, UK). All DNA
isolations of plasmid or PAC clones were carried out according to
protocols supplied with Qiagen columns (Chatsworth, CA, USA) or
with Magnum KB-100 columns (Genome System, St. Louis, MO,
USA), respectively. DNA fragments were puri¢ed on agarose gel,
extracted using a WIZARD DNA Clean-Up system (Promega, Mad-
ison, WI, USA), and radiolabeled with K-32P-dCTP (Amersham Phar-
macia Biotech, Rainham, UK) using a Rad-Prime labeling kit (Gibco-
BRL, Neu-Isenberg, Germany). For colony hybridizations, oligonu-
cleotides were labeled using Q-32P-dATP (Amersham-Pharmacia Bio-
tech) and T4 kinase (Gibco-BRL).
2.3. Nucleotide sequence analysis
Sequence reactions were performed using the dideoxy chain termi-
nation method with £uorescent detection on an ABI-PRISM-377 ap-
paratus (Perkin Elmer, Foster City, CA, USA), using plasmid-speci¢c
primers, and various gene-speci¢c walking primers. All primers were
designed using Oligo v5.0 software (Medprobe, Plymouth, MN, USA)
and synthesized by Gibco-BRL. All generated sequences were aligned
using STADEN software pregap and gap4.0 [12].
2.4. PCR and RACE experiments
PCR reactions were performed on an MJ Research PTC-200 appa-
ratus (MJ Research, Watertown, MA, USA). For every PCR reaction
2 mM of each dNTP (Sigma Chemical Co., St. Louis, MO, USA),
25 pmol of each primer, and 0.5 units of Taq DNA polymerase (Gib-
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co-BRL) was used in 1UPCR bu¡er (Gibco-BRL). Template DNA
amounts were estimated to be 50^100 ng. The typical PCR temper-
ature pro¢le was 3 min at 94‡C, 30 cycles of 30 s at 94‡C, 30 s at
optimal annealing temperature, and 1 min at 72‡C, followed by ¢nal
extension at 72‡C for 5 min.
RACE experiments were performed according to the Marathon
cDNA ampli¢cation protocol (Clontech Laboratories, Palo Alto,
CA, USA) using poly(A)+ selected (Micro-FastTrack, Invitrogen,
San Diego, CA, USA) fetal brain RNA (Clontech). RACE PCR re-
actions were done in ¢nal volumes of 50 Wl, using a Perkin-Elmer 2400
GeneAmp PCR system (Perkin Elmer) and the Advantage cDNA
polymerase mix (Clontech). Primers for the ¢rst 5P RACE experiment
were: MCB444 (5P-CACCACAGGCAAGAGATAGGTACTG-3P) as
GSP-1, and MCB445 (5P-TTTGGATTGACAGCAGCTAAACTGA-
3P) as GSP-2. The second 5P RACE experiment was carried out with
primers MCB779 (5P-TGTGCCAACTGGGGAGGATTCA-3P) as
GSP-1 and MCB780 (5P-TCCCCGATAAGCCTCCCATCTG-3P) as
GSP-2. RACE products were cloned in pGEMT (Promega, Madison,
WI, USA).
2.5. RNA isolation and Northern blot analysis
Total RNA was isolated using RNazol (WAK-Chemie-Medical,
Bad Homburg, Germany). Fetal brain RNA was from Clontech.
Most cell lines were obtained from the American Type Culture Col-
lection (Rockville, MD, USA). For Northern blot analysis 15 Wg total
RNA was glyoxylated [13], size-fractionated on a 1% agarose gel and
transferred to Hybond-N (Amersham). Hybridization of Northern
blots with the insert of EST clone I.M.A.G.E. 32430 was performed
according to Church and Gilbert [14]. The 285-bp cadherin-6-speci¢c
probe was obtained by standard PCR with genomic DNA as tem-
plate, using primers MCB275 (5P-GAATCTTACCTTGTGCAG-3P)
and MCB276 (5P-CATCTTTACTTCTTGGGT-3P) at an annealing
temperature of 54‡C. For quantity and quality control of the RNA
samples, Northern blots were stripped and checked by rehybridization
with a GAPDH probe. A human RNA Master Blot (Clontech) was
hybridized according to the manufacturer’s protocol using Express-
Hyb Hybridization solution (Clontech).
2.6. Isolation of the genomic PAC clone
Superpools and subsequent plate pools from the RPCI1 PAC li-
brary [15] were screened by PCR, using primers MCB363 (5P-AAT-
CACTTCCAAGAGCCA-3P) and MCB364 (5P-CAGGTTGCATAT-
CACACC-3P) at an annealing temperature of 54‡C. This resulted in
the plate number of a 384-well microtiter plate. PCR analysis of the
pooled rows and columns of this plate yielded the coordinates of a
positive well (31D12). Single colonies were puri¢ed and checked by
PCR. A positive colony was grown and used for DNA isolation.
Sequence analysis was done using primers MCB676 (5P-ATG-
CTGTCTCCACTTCACAA-3P) and MCB364 on PAC DNA as tem-
plate. About 820 bp of 3P UTR sequence was obtained, with 70 bp
positioned 3P of the cDNA poly-adenylation site (data not shown).
This excludes the possibility of having isolated a PAC clone speci¢c
for a processed pseudogene.
2.7. FISH analysis
FISH analysis using the human cadherin-10-speci¢c PAC clone was
performed according to standard procedures [16]. DNA of the PAC
clone and centromere-5 probe was biotinylated using a BioNick kit
(Gibco-BRL). Fluorescent images were captured by a Photometrics
Image Point CCD camera (Photometrics, Mu«nchen, Germany)
mounted on a Zeiss Axiophot microscope. Image processing and
chromosome G-banding was obtained by reverse DAPI-banding, us-
ing the MacProbe v3.4.1 software (Perceptive Scienti¢c International,
League City, TX, USA). The chromosome 5 centromeric probe was a
gift from Dr. F. Speleman (Department of Medical Genetics, Univer-
sity Hospital, Ghent, Belgium).
3. Results and discussion
3.1. Determination of the full-length cDNA sequence of
cadherin-10
In an attempt to identify novel members of the cadherin
superfamily, our database analysis revealed the existence of
several putative cadherin-like genes. For one of these, the
representative clone I.M.A.G.E. 32430 was obtained from
the UK-HGMP Resource Centre and sequenced. A BLAST-
N search [11], with the sequence obtained for the 1450-bp
insert of the EST clone, showed high similarity to the human
cadherin-6 and chicken cadherin-10 cDNAs, but failed to in-
dicate that it was identical to other already described human
cadherin sequences.
Additional sequence data from the 5P end of the cadherin-
like transcript was obtained after cloning of the products of a
5P RACE experiment using the gene-speci¢c primers MCB444
and MCB445. The RACE clone sequences partially over-
lapped the previously obtained sequence, giving a full match
in the overlapping area. However, they failed to reveal the
presumed start codon, making further 5P RACE experiments
obligatory. The remaining coding sequence and part of the 5P
UTR were obtained by subsequent 5P RACE experiments us-
ing the primers MCB779 and MCB780.
BLAST-N searches of the resulting composed sequence of
3966 bp (Fig. 1, Genbank Acc. No. AF039747) revealed a
sequence almost identical to the rat cadherin-10 cDNA
(Acc. No. I34427; Suzuki et al., unpublished data). However,
the latter sequence of 2490 bp is not complete as translation
of its largest open reading frame (ORF) produces a protein of
618 amino acid residues, which should lack about 170 amino
acid residues of the N-terminal. Within US patent 5597725-A
a 730-bp, and therefore incomplete, sequence of the human
cadherin-10 gene appeared to be identical to our sequence.
The cadherin-10 sequence encodes a 2367-bp ORF with a
putative start codon on position 1036, and a TAA stop codon
on position 3402. The start codon does not fully match the
Kozak consensus sequence for a ideally translationable start
codon [17]. However, we assume this codon to be the correct
start site since a stop codon is present just upstream of the
start codon, because of the absence of better start codons in
the vicinity, and because of a similar position of the start
codon of the highly homologous chicken cadherin-10 se-
quence [18]. The ORF encodes a 788 amino acid protein,
with ¢ve extracellular cadherin repeats containing the charac-
teristic conserved amino acid residues [1].
The mature cadherin-10 protein is most likely generated
after cleavage of the 54 amino acid predomain. This domain
contains a signal sequence for endoplasmic reticulum import,
which is less well conserved between species. Chicken and
human cadherin-10 di¡er by 46% (25 out of 54 amino acid
residues) in the predomain, while the remaining part of the
protein shows less than 5% di¡erence (33 out of 735 amino
acid residues). The mature protein would start with a glycine
residue (Fig. 1) since this amino acid is preceded by a 4 amino
acid proprotein cleavage signal (RQKR) characteristic for fur-
in, a member of the subtilisin family of proprotein convertases
[19]. This cleavage signal can be observed in various other
cadherins, and is indeed recognized by these protein conver-
tases [20].
Remarkably, in many cadherins a similar recognition site
can be observed just cytoplasmic of the transmembrane do-
main. However, it is unclear whether this sequence can be
actually cleaved as the convertases are not supposed to be
present within the cytoplasm. One obvious experiment would
be to mutagenize this putative proteolytic site and to look for
di¡erences in cellular behavior. Indeed, cleavage of this site
would lead to a truncated cadherin molecule without cytoplas-
mic tail, and therefore with impaired cell adhesive capacities.
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Fig. 1. cDNA sequence and predicted amino acid sequence of human cadherin-10. The possible proteolytic cleavage site of the precursor pro-
tein is indicated with a ¢lled triangle. The recognition sequence is boxed and given in bold, while the putative other recognition sequence site is
only boxed. The transmembrane region is underlined. The start codon and poly(A)-adenylation signal are boxed. Relevant stop codons are in-
dicated by an asterisk. The Genbank Accession number is AF039747.
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Although there are no observations so far that support cleav-
age at this site, the high evolutionary conservation of the
sequence is intriguing (see also Fig. 5A).
3.2. Expression pattern of the human cadherin-10 gene
Northern blot analysis using total RNA of a variety of cell
lines and also fetal brain was performed to determine the
length of the cadherin-10 transcripts (Fig. 2). Cadherin-10
transcripts were only present in fetal brain total RNA. The
length of the transcripts was estimated to be 3.6^4.0 kb. The
obtained sequence of 3699 bp might therefore be complete.
In addition we investigated the human cadherin-10 expres-
sion using a panel of poly(A)+ selected RNA from di¡erent
tissues spotted on a membrane. Our results (Fig. 3) indicate
expression of cadherin-10 in almost all brain-derived tissues
including pituitary gland (rows A and B, G1 and D4), and
signi¢cant expression in adult and fetal kidney (Fig. 3; E1 and
G3, respectively). Weak expression was demonstrated for me-
dulla oblongata, prostate, lymph node, and fetal lung (Fig. 3).
All other tissues, including some major components of the
human body (liver, skin, skeletal muscle, heart), did not
show detectable cadherin-10 expression.
An extensive study on the chicken cadherin-10 expression
demonstrated its presence from an early stage, persisting until
the hatching stage [18]. Furthermore, cadherin-10 expression
re£ected the neuromeric organization of the brain and was
present in speci¢c gray matter structures of all major divisions
in the chicken brain. Our results indicate that cadherin-10 is
also expressed in adult human brain, at least at the mRNA
level.
It is noteworthy that the cadherin-12 (BR-cadherin) protein
is exclusively expressed in human brain, although the mRNA
has been observed in other tissues as well, suggesting post-
transcriptional control [21]. It is therefore possible that the
cadherin-10 expression we detected in fetal and adult kidney
is also restricted to the mRNA level in these tissues.
Human cadherin-6 is a closely related family member of
cadherin-10. This suggests possible cross-hybridization of the
cadherin-10 cDNA probe used in the expression analysis with
human cadherin-6 transcripts. DNA sequence comparison
showed that about half of the probe has a 75% homology
with the coding sequence of cadherin-6. The other part of
the probe consists of the 3P UTR, with a very low homology
to the cadherin-6 cDNA. Northern blot hybridization of two
identical blots with fetal brain RNA, using either the cadher-
in-10 probe or the cadherin-6-speci¢c probe, demonstrated
non-identical sizes for the cadherin-10 and cadherin-6 tran-
scripts, and therefore lack of cross-hybridization (data not
shown). Therefore, it is very unlikely that our cadherin-10
probe also detects cadherin-6 transcripts in the multiple tissue
master blot (Fig. 3). Moreover, we detected cadherin-10
Fig. 2. Expression analysis of human cadherin-10. Upper panel:
Northern blot of human cell lines. Markers are 28S and 18S riboso-
mal RNA. Lower panel shows signals of a control GAPDH hybrid-
ization on the same ¢lter. Tissue RNA and cell lines are as follows:
fetal brain (1), MCF7 breast carcinoma (2), B-CPAP thyroid carci-
noma (3), GLC8 small-cell lung cancer (4), SW872 liposarcoma (5),
SK-LMS-1 leiomyosarcoma (6), MKN45 gastric carcinoma (7),
HOS osteosarcoma (8), SW1353 chondrosarcoma (9), SW620 colon
carcinoma cells (10), and FS4 ¢broblasts (11).
Fig. 3. A: RNA master blot hybridized with the same probe as in Fig. 2. RNA and control samples are as indicated in panel B.
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mRNA in human lung and kidney by gene-speci¢c RT-PCR
(data not shown). This indicates that the expression patterns
of both genes overlap to some extent. Cadherin-6 appeared to
be present as protein in proximal renal tube epithelia, fetal
kidney, and renal cell carcinomas [22]. In the latter tumors a
correlation was observed between aberrant cadherin-6 protein
expression (i.e. heterogenous or no expression) and poor prog-
nosis [22]. Although the latter authors did not detect human
cadherin-6 mRNA in the brain by Northern blot analysis,
mouse cadherin-6 mRNA is present in speci¢c brain areas
[23]. The areas expressing cadherin-6 appeared to be synapti-
cally connected and delineated restricted neuronal circuits
[24]. Similar data were obtained for the chicken cadherin-6B
protein. This molecule is highly related to human and mouse
cadherin-6 and shows a restricted expression in speci¢c neuro-
nal circuits of the visual and cerebellar system of the chicken
brain [25,26].
3.3. Chromosomal localization of the human cadherin-10 by
FISH analysis
A cadherin-10-speci¢c PAC clone was used in a FISH anal-
ysis on metaphase spreads of a healthy male donor. Each time
speci¢c signals (often double) were observed on the p-arm of a
relatively large chromosome. Reverse DAPI-banding sug-
gested the chromosomal localization to be 5p13^14, which
was con¢rmed using a chromosome 5-speci¢c centromere
probe (Fig. 4). This is the same localization as described for
the cadherin-12 gene [27], suggesting a potential clustering of
these two cadherin genes.
Recently, the human cadherin-6 and cadherin-14 (CDH18)
genes were assigned to chromosomal region 5p14^15 [28]. The
method used was radiation hybrid mapping, which is rather
accurate but does not always allow assignment to the correct
chromosomal band. Therefore, it is conceivable that the hu-
man cadherin-10 gene is more tightly clustered to the three
other cadherin genes than is indicated by the di¡erent chro-
mosomal bands. The high overall sequence homology and
gene clustering suggests that the cadherin-10 and cadherin-6
genes might be the result of a recent gene duplication.
3.4. Phylogenetic analysis of the human cadherin-10 gene
The deduced protein sequence of cadherin-10 was used for
screening of the database libraries (BLAST-P). The resulting
hits were cadherin-6 and cadherin-10 proteins of various spe-
cies. In addition, the mouse T2-cadherin, isolated from thy-
mocytes [10], was identi¢ed as a possible orthologue.
Phylogenetic analysis was performed with that part of the
protein sequences that was available for all sequences of in-
terest, i.e. the last 265 amino acid residues encoded by the
human cadherin-10 cDNA (containing part of the extracellu-
lar domain 5, the complete transmembrane region and cyto-
plasmic tail). This small region is similar to the known se-
quence of the mouse T2-cadherin. Corresponding regions of
the following cDNAs were also included in the analysis :
chicken and rat cadherin-10, human, mouse and rat cadher-
in-6, and chicken cadherin-6B sequences. Sequences of two
more representatives of the atypical (type-II) cadherins, i.e.
human cadherin-8 and cadherin-12, and of two classical
(type-I) cadherins, i.e. human E-cadherin and N-cadherin,
were also included. The results (Fig. 5), indicate the high
conservation of our novel sequence with the chicken and rat
cadherin-10, while other close family members (e.g. three
mammalian cadherin-6 molecules plus chicken cadherin-6B)
are clearly di¡erent. We therefore conclude that our cDNA
sequence encodes the genuine human cadherin-10 gene, while
the mouse T2-cadherin is most likely the mouse orthologue.
Interestingly, the similarity between the human cadherin-6
and cadherin-10 proteins is large with respect to that seen
between the classical E-cadherin and N-cadherin molecules.
In addition, the two other analyzed human type-II cadherins
(cadherin-8 and cadherin-12) show also a lower similarity.
This might re£ect a close evolutionary relationship between
cadherin-6 and cadherin-10, and possibly partly shared func-
tions.
The di¡erences between the cytoplasmic domains of the
human type-I classical cadherins (demonstrated here for E-
and N-cadherin) and cadherin-10 are relatively large. For cad-
herin-10, this may suggest a weak binding activity towards the
cytoplasmic protein L-catenin (or plakoglobin), resulting in
weak cell adhesive properties. However, two recent papers
indicate that also the related type-II cadherins, cadherin-6
[22] and cadherin-14 [29] (with a new gene signature
CDH18, www.gene.ucl.ac.uk/nomenclature), are capable of
binding L-catenin, suggesting a similar functionality of these
cadherins in cell-cell adhesion, or even other functions.
An unexpected role for two classical cadherins, E-cadherin
and N-cadherin, was suggested in a recent paper [30]. Func-
tional disruption of these cadherins, by either blocking anti-
bodies or adhesion-inhibiting polypeptides, prevented the in-
duction of long-term potentiation in rat hippocampal slices.
Combined with the reported expression of a variety of cad-
herins in mammalian brains (reviewed in [31]), this suggests
that cadherins might play a role not only in establishing the
brain structure but possibly also in forming the memory. It
remains to be determined whether the human cadherin-10 has
a function in cell-cell adhesion, and what its role in the human
brain is.
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Fig. 4. Chromosomal localization of the cadherin-10 gene. Repre-
sentative example of a FISH analysis using a cadherin-10-speci¢c
PAC clone. Open arrows mark the signals of the chromosome cen-
tromere 5 probe; closed arrows indicate the signal position of the
cadherin-10-speci¢c PAC probe. The long arm (q) and short arm
(p) of one chromosome 5 are indicated.
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